$BIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-RAD LABORATORIES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-RAD LABORATORIES, INC.. Get notifications about new insider transactions in BIO-RAD LABORATORIES, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Option Exercise | A | 0.00 | 1,733 | 0 | 1,733 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | RAMALINGAM AJIT | SVP, Chief Accounti ... | Option Exercise | A | 0.00 | 963 | 0 | 963 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 326.15 | 500 | 163,075 | 2,000 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 215.98 | 1,000 | 215,980 | 1,500 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 160.37 | 1,200 | 192,444 | 800 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 139.56 | 2,000 | 279,120 | 500 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 119.54 | 3,000 | 358,620 | 0 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 117.00 | 3,200 | 374,400 | 0 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 107.32 | 3,250 | 348,790 | 0 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 98.04 | 3,500 | 343,140 | 0 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 84.57 | 3,500 | 295,995 | 0 | |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 521.86 | 339 | 176,911 | 20,738 | 21.1 K to 20.7 K (-1.61 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 520.94 | 5,668 | 2,952,688 | 21,077 | 26.7 K to 21.1 K (-21.19 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 519.89 | 1,133 | 589,035 | 26,745 | 27.9 K to 26.7 K (-4.06 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 518.76 | 5,392 | 2,797,154 | 27,878 | 33.3 K to 27.9 K (-16.21 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 517.64 | 315 | 163,057 | 33,270 | 33.6 K to 33.3 K (-0.94 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 326.15 | 500 | 163,075 | 33,585 | 33.1 K to 33.6 K (+1.51 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 215.98 | 1,000 | 215,980 | 33,085 | 32.1 K to 33.1 K (+3.12 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 160.37 | 1,200 | 192,444 | 32,085 | 30.9 K to 32.1 K (+3.89 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 139.56 | 2,000 | 279,120 | 30,885 | 28.9 K to 30.9 K (+6.92 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 119.54 | 3,000 | 358,620 | 28,885 | 25.9 K to 28.9 K (+11.59 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 117.00 | 3,200 | 374,400 | 25,885 | 22.7 K to 25.9 K (+14.11 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 107.32 | 3,250 | 348,790 | 22,685 | 19.4 K to 22.7 K (+16.72 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 98.04 | 3,500 | 343,140 | 19,435 | 15.9 K to 19.4 K (+21.96 %) |
Aug 21 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 84.57 | 3,500 | 295,995 | 15,935 | 12.4 K to 15.9 K (+28.15 %) |
Aug 19 2020 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Sell | S | 518.81 | 2,382 | 1,235,805 | 12,435 | 14.8 K to 12.4 K (-16.08 %) |
Jun 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 84.57 | 37,000 | 3,129,090 | 0 | |
Jun 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 448.85 | 21,860 | 9,811,861 | 295,122 | 317 K to 295.1 K (-6.90 %) |
Jun 15 2020 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 84.57 | 37,000 | 3,129,090 | 316,982 | 280 K to 317 K (+13.22 %) |
Jun 02 2020 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 485.40 | 1,500 | 728,100 | 2,310 | 3.8 K to 2.3 K (-39.37 %) |
May 14 2020 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Sell | S | 457.35 | 443 | 202,606 | 4,140 | 4.6 K to 4.1 K (-9.67 %) |
May 01 2020 | BIO | BIO-RAD LABORATORI ... | RAMALINGAM AJIT | EVP, Chief Accounti ... | Option Exercise | A | 0.00 | 1,384 | 0 | 1,384 | |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,000 | 0 | 4,000 | |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 436.27 | 346 | 150,949 | 680 | 1 K to 680 (-33.72 %) |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,000 | 0 | 1,026 | 26 to 1 K (+3,846.15 %) |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 700 | 0 | 2,800 | |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Payment of Exercise | F | 403.06 | 243 | 97,944 | 457 | 700 to 457 (-34.71 %) |
Apr 09 2020 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, Chief Financia ... | Buy | M | 0.00 | 700 | 0 | 700 | 0 to 700 |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ ALICE N | Director | Gift | G | 0.00 | 240 | 0 | 438,680 | 438.9 K to 438.7 K (-0.05 %) |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ ALICE N | Director | Gift | G | 0.00 | 2,690 | 0 | 1,793,621 | 1.8 M to 1.8 M (-0.15 %) |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ STEVEN D | 10% Owner | Gift | G | 0.00 | 40 | 0 | 12,811 | 12.8 K to 12.8 K (+0.31 %) |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ STEVEN D | 10% Owner | Gift | G | 0.00 | 40 | 0 | 25,039 | 25 K to 25 K (+0.16 %) |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Gift | G | 0.00 | 40 | 0 | 12,811 | 12.8 K to 12.8 K (+0.31 %) |
Dec 27 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Gift | G | 0.00 | 40 | 0 | 279,982 | 279.9 K to 280 K (+0.01 %) |
Dec 17 2019 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Option Exercise | A | 366.89 | 2,511 | 921,261 | 2,511 | |
Dec 17 2019 | BIO | BIO-RAD LABORATORI ... | WRIGHT DARA | Executive Vice Pres ... | Option Exercise | A | 0.00 | 2,511 | 0 | 2,511 | |
Dec 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 159.32 | 1,250 | 199,150 | 1,250 | |
Dec 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 370.12 | 656 | 242,799 | 456 | 1.1 K to 456 (-58.99 %) |
Dec 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 370.11 | 1,250 | 462,638 | 1,112 | 2.4 K to 1.1 K (-52.92 %) |
Dec 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 159.32 | 1,250 | 199,150 | 2,362 | 1.1 K to 2.4 K (+112.41 %) |
Nov 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Sell | S | 351.45 | 848 | 298,030 | 0 | 848 to 0 (-100.00 %) |
Sep 16 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 330.00 | 522 | 172,260 | 2,410 | 2.9 K to 2.4 K (-17.80 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 139.56 | 600 | 83,736 | 600 | |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 119.54 | 600 | 71,724 | 0 | |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 329.00 | 41 | 13,489 | 18,728 | 18.8 K to 18.7 K (-0.22 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 328.25 | 797 | 261,615 | 18,769 | 19.6 K to 18.8 K (-4.07 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 139.56 | 600 | 83,736 | 600 | |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 139.56 | 600 | 83,736 | 19,566 | 19 K to 19.6 K (+3.16 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 119.54 | 600 | 71,724 | 0 | |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 119.54 | 600 | 71,724 | 18,966 | 18.4 K to 19 K (+3.27 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 329.00 | 41 | 13,489 | 18,728 | 18.8 K to 18.7 K (-0.22 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 328.25 | 797 | 261,615 | 18,769 | 19.6 K to 18.8 K (-4.07 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 139.56 | 600 | 83,736 | 19,566 | 19 K to 19.6 K (+3.16 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 119.54 | 600 | 71,724 | 18,966 | 18.4 K to 19 K (+3.27 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 600 | |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 326.42 | 298 | 97,273 | 18,366 | 18.7 K to 18.4 K (-1.60 %) |
Sep 13 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 18,664 | 18.1 K to 18.7 K (+3.32 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 600 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 326.42 | 238 | 77,688 | 2,932 | 3.2 K to 2.9 K (-7.51 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 3,170 | 2.6 K to 3.2 K (+23.35 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 322.93 | 139 | 44,887 | 2,570 | 2.7 K to 2.6 K (-5.13 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 400 | 0 | 2,709 | 2.3 K to 2.7 K (+17.32 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,200 | 0 | 3,200 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,000 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 326.42 | 1,587 | 518,029 | 279,942 | 281.5 K to 279.9 K (-0.56 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,200 | 0 | 281,529 | 278.3 K to 281.5 K (+1.15 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 322.93 | 992 | 320,347 | 278,329 | 279.3 K to 278.3 K (-0.36 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,000 | 0 | 279,321 | 277.3 K to 279.3 K (+0.72 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 300 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 326.42 | 104 | 33,948 | 848 | 952 to 848 (-10.92 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 952 | 652 to 952 (+46.01 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 322.93 | 70 | 22,605 | 652 | 722 to 652 (-9.70 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 200 | 0 | 722 | 522 to 722 (+38.31 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 500 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 326.42 | 248 | 80,952 | 14,817 | 15.1 K to 14.8 K (-1.65 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 15,065 | 14.6 K to 15.1 K (+3.43 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 322.93 | 199 | 64,263 | 14,565 | 14.8 K to 14.6 K (-1.35 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 14,764 | 14.4 K to 14.8 K (+2.78 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 150 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 326.42 | 52 | 16,974 | 4,567 | 4.6 K to 4.6 K (-1.13 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 150 | 0 | 4,619 | 4.5 K to 4.6 K (+3.36 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 322.93 | 52 | 16,792 | 4,469 | 4.5 K to 4.5 K (-1.15 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 150 | 0 | 4,521 | 4.4 K to 4.5 K (+3.43 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 322.93 | 298 | 96,233 | 18,064 | 18.4 K to 18.1 K (-1.62 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 18,362 | 17.8 K to 18.4 K (+3.38 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 600 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 389 | 0 | 0 | |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 326.42 | 231 | 75,403 | 3,810 | 4 K to 3.8 K (-5.72 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 4,041 | 3.4 K to 4 K (+17.44 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 322.93 | 135 | 43,596 | 3,441 | 3.6 K to 3.4 K (-3.78 %) |
Sep 12 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 389 | 0 | 3,576 | 3.2 K to 3.6 K (+12.21 %) |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 159.32 | 600 | 95,592 | 1,200 | |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 336.47 | 444 | 149,393 | 17,762 | 18.2 K to 17.8 K (-2.44 %) |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 159.32 | 600 | 95,592 | 18,206 | 17.6 K to 18.2 K (+3.41 %) |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,000 | 0 | 6,000 | |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 339.71 | 1,488 | 505,488 | 277,321 | 278.8 K to 277.3 K (-0.53 %) |
Sep 10 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 3,000 | 0 | 278,809 | 275.8 K to 278.8 K (+1.09 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 335.59 | 199 | 66,782 | 14,364 | 14.6 K to 14.4 K (-1.37 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 14,563 | 14.2 K to 14.6 K (+2.82 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 170 | 0 | 340 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 180 | 0 | 540 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 335.59 | 59 | 19,800 | 4,371 | 4.4 K to 4.4 K (-1.33 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 170 | 0 | 4,430 | 4.3 K to 4.4 K (+3.99 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 339.48 | 63 | 21,387 | 4,260 | 4.3 K to 4.3 K (-1.46 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 180 | 0 | 4,323 | 4.1 K to 4.3 K (+4.34 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 326.15 | 600 | 195,690 | 2,400 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 215.98 | 1,200 | 259,176 | 1,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 159.32 | 1,200 | 191,184 | 1,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 139.56 | 1,800 | 251,208 | 1,200 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 119.54 | 2,400 | 286,896 | 600 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 335.59 | 298 | 100,006 | 17,606 | 17.9 K to 17.6 K (-1.66 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 17,904 | 17.3 K to 17.9 K (+3.47 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 340.00 | 100 | 34,000 | 17,304 | 17.4 K to 17.3 K (-0.57 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 338.97 | 543 | 184,061 | 17,404 | 17.9 K to 17.4 K (-3.03 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 338.01 | 750 | 253,508 | 17,947 | 18.7 K to 17.9 K (-4.01 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 336.80 | 1,231 | 414,601 | 18,697 | 19.9 K to 18.7 K (-6.18 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 335.64 | 1,871 | 627,982 | 19,928 | 21.8 K to 19.9 K (-8.58 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Sell | S | 334.77 | 700 | 234,339 | 21,799 | 22.5 K to 21.8 K (-3.11 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 326.15 | 600 | 195,690 | 22,499 | 21.9 K to 22.5 K (+2.74 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 215.98 | 1,200 | 259,176 | 21,899 | 20.7 K to 21.9 K (+5.80 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 159.32 | 1,200 | 191,184 | 20,699 | 19.5 K to 20.7 K (+6.15 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 139.56 | 1,800 | 251,208 | 19,499 | 17.7 K to 19.5 K (+10.17 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 119.54 | 2,400 | 286,896 | 17,699 | 15.3 K to 17.7 K (+15.69 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 339.48 | 208 | 70,612 | 15,299 | 15.5 K to 15.3 K (-1.34 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 15,507 | 14.9 K to 15.5 K (+4.02 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 335.59 | 208 | 69,803 | 2,309 | 2.5 K to 2.3 K (-8.26 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 2,517 | 1.9 K to 2.5 K (+31.30 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 340.00 | 371 | 126,140 | 1,917 | 2.3 K to 1.9 K (-16.22 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 339.48 | 208 | 70,612 | 2,288 | 2.5 K to 2.3 K (-8.33 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 2,496 | 1.9 K to 2.5 K (+31.65 %) |